Your browser doesn't support javascript.
loading
Erratum to: Phase 1 study of darolutamide (ODM-201), a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer.
Matsubara, Nobuaki; Mukai, Hirofumi; Hosono, Ako; Onomura, Mai; Sasaki, Masaoki; Yajima, Yoko; Hashizume, Kensei; Yasuda, Masanobu; Uemura, Miho; Zurth, Christian.
Affiliation
  • Matsubara N; Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan. nmatsuba@east.ncc.go.jp.
  • Mukai H; Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.
  • Hosono A; Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.
  • Onomura M; Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.
  • Sasaki M; Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.
  • Yajima Y; Clinical Development, Bayer Yakuhin, Osaka, Japan.
  • Hashizume K; Clinical Sciences Japan, Bayer Yakuhin, Osaka, Japan.
  • Yasuda M; Clinical Statistics, Bayer Yakuhin, Osaka, Japan.
  • Uemura M; Clinical Sciences Japan, Bayer Yakuhin, Osaka, Japan.
  • Zurth C; Clinical Pharmacology Oncology, Bayer AG, Berlin, Germany.
Cancer Chemother Pharmacol ; 80(6): 1073-1077, 2017 12.
Article in En | MEDLINE | ID: mdl-29063294
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Chemother Pharmacol Year: 2017 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Chemother Pharmacol Year: 2017 Document type: Article Affiliation country: